Park Medi World Limited (PARKHOSPS)
Park Group of Hospitals declares Q1 FY''27 Unaudited Results
Press Release - Q1 FY27
- Revenue 4.76bn +19% y-y; EBITDA 1.26bn +20% y-y (margin 26.5%, +20 bps); Net Profit 886mn +35% y-y (margin 18.6%, +220 bps)
- Commissioned largest greenfield hospital in Panchkula (350 beds) in Apr 2026
- Signed agreements to acquire Medicity Hospital Rudrapur (INR 177 cr) and Mehar Hospital Zirakpur (INR 107 cr), commissioning by Nov 2026
- Expansion of Palam Vihar hospital by 100 beds, commissioning Nov 2026; consolidated Gurugram capacity 750 beds
- Total bed capacity to grow 46% in 2026 with 1,490 new beds, largest addition ever
- Negligible term debt (INR 256 mn) and strong liquidity (INR 2,998 mn in fixed deposits)
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 PARKHOSPS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add PARKHOSPS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Park Medi World Limited
Important.
The summary above is generated automatically from Park Medi World Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.